Health
Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease
SINGAPORE, Sept. 15, 2020 /PRNewswire/ -- Concept Medical Inc.,
2020-09-15 03:41
3414
Seelos Announces Issuance of a New Patent and an Additional Notice of Allowance in Japan for Intranasal Racemic Ketamine (SLS-002)
Patents Further Strengthen Global Intellectual Property Portfolio in Psychiatry NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare ...
2020-09-14 21:00
7675
TIKOMED'S ILB(R) restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants
VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain injury ...
2020-09-14 20:35
1801
PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020
DAEJEON, South Korea, Sept. 14, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) today announced positive data from its two combination trials of olinvacimab, its leading clinical candidate in oncology, with MSD's pembrolizumab at the 13th Annual Meeting of the Korean Society of Medical O...
2020-09-14 20:00
1530
NASIR-HCC: Phase 2 study of Sirtex Medical SIR-Spheres(R) Y-90 resin microspheres followed by Nivolumab therapy demonstrates favorable safety and tolerability profile at ILCA 2020
WOBURN, Massachusetts, Sept. 14, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapy, SIR-Spheres®Y-90 resin microspheres, is pleased to report that positive trial data from the NASIR-HCC Study was reported by ProfessorBruno Sangro at the ...
2020-09-14 20:00
1655
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Granted Orphan Drug Designation by the FDA for the Treatment of Gastric Cancer
SUZHOU, China and ROCKVILLE, Md., Sept. 14, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug ...
2020-09-14 18:35
1908
Innovent and Lilly Jointly Announce Results of Six Clinical Studies of TYVYT® (sintilimab injection) to be Presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
SAN FRANCISCO and SUZHOU, China, Sept. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major disea...
2020-09-14 18:00
12649
Countering counterfeit medicines in the fast-paced world of e-commerce
BANGKOK, Sept. 14, 2020 /PRNewswire/ -- Research shows that counterfeit medicine cannot cure illnesses and can cause moreharm to your health. Counterfeit medicines have been in the market for a long time, and without sufficient awareness, consumption of these substances can lead to unexpected sy...
2020-09-14 16:59
3350
Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
* New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer * Overall efficacy data, and analyses of brain metastases and HRQoL for tepotinib† from largest ongoing st...
2020-09-14 10:41
2479
Global Fund Partnership Has Saved 38 Million Lives - but COVID-19 Could Wipe Out Progress
GENEVA, Sept. 14, 2020 /PRNewswire/ -- A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic. According to ...
2020-09-14 10:39
3456
Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist
SHANGHAI, Sept. 14, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that it has filed investigational new drug application (IND) with US FDA for its non-alcoholic steatohepatitis (NASH) drug candidate ASC42. ASC42 is an in-...
2020-09-14 08:30
3408
Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market
SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more th...
2020-09-14 08:17
3382
5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global capacity expansion
* Total planned investment is around 500 million USD over five years to raise manufacturing capacity * Continues long-term strategy of increasing capacity to respond to growing industry demand and new market opportunities * Cytiva hiring nearly 1,000 personnel in Austria, China, Singapore, S...
2020-09-14 03:00
2982
Coronavirus Breakthrough: Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient - Discharged Following Five Days of Treatment
TAIPEI and SAN DIEGO, Sept. 11, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announced today that the first patient with severe COVID-19 demonst...
2020-09-12 08:34
3415
Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting
LONDON, Sept. 12, 2020 /PRNewswire/ -- Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research: Dr Andrew Pitsillides, Professor of Skeletal Dynamics at the Royal Veterinary College, London presented 'NaQuinate: A Drug that Selectively Synergize...
2020-09-12 05:00
6134
SK Biopharmaceuticals Initiates Clinical Development Program for Cenobamate in Asia
Phase 3 clinical trial to support registrational filings in China and Japan Company on track to expand presence in Asia, reflecting its commitment to reach more people with epilepsy worldwide PANGYO, GYEONGGI PROVINCE, Korea, Sept. 12, 2020 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a glo...
2020-09-12 03:13
5385
Harbour BioMed and Hualan Genetic Announced Collaboration to Develop Multiple Innovative Antibody Programs
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, SUZHOU,China and XINXIANG, China, Sept. 11, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company today announced a strategic partnership agreement with Hualan Genetic Engineering Co., Ltd (Hualan Geneti...
2020-09-11 21:33
7231
NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients
TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Genovate Biotech (TPEX:4130) subsidiary andTaiwan-based focused ultrasound (FUS) manufacturer NaviFUS Corporation is pleased to announce the start of its clinical trial (NCT04446416) for the combination of FUS plus bevacizumab therapy. Researchers at Linkou ...
2020-09-11 20:55
3638
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical trial program Data f...
2020-09-11 20:00
5687
Booming Demand for Innodisk's CAN Bus Solutions Amid Pandemic and Autonomous Vehicle Trend
TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Innodisk's CAN bus expansion modules are taking the world by storm. Unprecedented demand for autonomous vehicle technology amid the ongoing COVID-19 pandemic and continued growth of industrial automation and smart healthcare mean that Innodisk's industry-le...
2020-09-11 15:45
3760
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 310 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 281 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
5254
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
5238
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
3882
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
3573
